Cerebrovascular markers in lowered cognitive function

Journal of Alzheimer's Disease

Volumn 42, Issue , 2014, Pages S383-S391

  Mataró, Maria ^a   Soriano Raya, Juan José ^a   López Olóriz, Jorge ^a   Miralbell, Júlia ^a   Dacosta Aguayo, Rosalia ^a,b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

Biomarkers; blood markers; cerebrovascular disease; cognitive impairment; MRI markers; sonographic markers

Indexed keywords

BIOLOGICAL MARKER;

ARTERIAL WALL THICKNESS; ATHEROSCLEROTIC PLAQUE; BRAIN ATROPHY; BRAIN HEMORRHAGE; BRAIN INFARCTION; CEREBROVASCULAR DISEASE; COGNITION; COGNITIVE DEFECT; HEMODYNAMICS; HUMAN; NEUROIMAGING; REVIEW; WHITE MATTER; BLOOD; COGNITION DISORDERS; COMPLICATION;

BIOLOGICAL MARKERS; CEREBROVASCULAR DISORDERS; COGNITION DISORDERS; HUMANS;

EID: 84908152534     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-141443     Document Type: Review

References (74)

1. Cummings JL, Doody R, Clark C (2007) Disease-modifying therapies for Alzheimer disease: Challenges to early intervention. Neurology 69, 1622-1634.
2. Pantoni L, Poggesi A, Inzitari D (2009) Cognitive decline and dementia related to cerebrovascular diseases: Some evidence and concepts. Cerebrovasc Dis 27, 191-196.
3. Hachinski VC, Bowler JV (1993) Vascular dementia. Neurology 43, 2159-2160.
4. Gorelick PB, Scuteri A, Black SE, Decarli C, Greenberg SM, Iadecola C, Launer LJ, Laurent S, Lopez OL, Nyenhuis D, Petersen RC, Schneider JA, Tzourio C, Arnett DK, Bennett DA, Chui HC, Higashida RT, Lin d quist R, Nilsson PM, Roman GC, Sellke FW, Seshadri S, American Heart Association Stroke Council, Council on Epidemiology, Prevention, Council on Cardiovascular Nursing, Council on Cardiovascular Radiology, Intervention, Council on Car d iovascular Surgery, Anesthesia (2011) Vascular contributions to cognitive impairment and dementia: A statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 42, 2672-2713.
5. Iadecola C (2010) The overlap between neurodegenerative and vascular factors in the pathogenesis of dementia. Acta Neuropathol 120, 287-296.
6. Pantoni L (2010) Cerebral small vessel disease: From pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol 9, 689-701.
7. Erkinjuntti T (2007) Vascular cognitive deterioration and stroke. Cerebrovasc Dis 24, 189-194.
8. Heringa SM, Bouvy WH, van den Berg E, Moll AC, Kappelle LJ, Biessels GJ (2013) Associations between retinal microvascular changes and dementia, cognitive functioning, and brain imaging abnormalities: A systematic review. J Cereb Blood Flow Metab 33, 983-995.
9. Xiong YY, Mo k V (2011) Age-related white matter changes. Aging Res 2011, ID 617927.
10. Basile AM, Pantoni L, Pracucci G, Asplund K, Chabriat H, Erkinjuntti T, Fazekas F, Ferro JM, Hennerici M, O'Brien J , ScheltensP,VisserMC,WashlundLO,Waldemar G,Wallin A, InzitariD,StudyLADIS,Group(2006)Age,hypertension,and lacunar stroke are themajordeterminants of the severity of agerelated white matter changes. The LADIS (Leukoaraiosis and Disability in the Elderly) Study. Cerebrovasc Dis 21, 315-322.
11. Longstreth WT Jr., Manolio TA, Arnold A, Burke GL, Bryan N, Jungreis CA, Enright PL, O'Leary D, Fried L (1996) Clinical correla tes of white matter findings on cranial magnetic resonance imaging of 3301 elderly people: The Cardiovascular Health Study. Stroke 27, 1274-1282.
12. Schmidt R, Grazer A, Enzinger C, Ropele S, Homayo on N, Pluta-Fuerst A, Schwingenschuh P, Katskchnig P, Cavalieri M, Schmidt H, Langkammer C, Ebner F, Fazekas F (2011) MRI-detected white matter lesions: Do they really matter? J Neural Transm 118, 673-681.
13. Pantoni L, Poggesi A, Inzitari D (2007) The relation between white-matter lesions and cognition. Curr Opin Neurol 20, 390-397.
14. Prins ND, van Dijk EJ, den Heijer T, Vermeer SE, Koudstaal PJ, Oudkerk M, Hofman A, Breteler MM (2004) Cerebral white matter lesions and the risk of dementia. Arch Neurol 61, 1531-1534.
15. Debette S, Markus HS (2010) The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: Systematic review and meta-Analysis. BMJ 341, c3666.
16. Boland zadeh N, Davis JC, TamR, Handy TC, Liu-Ambrose T (2012) The association between cognitive function and white matter lesion location in older adults: A systematic review. BMC Neurol 12, 126.
17. Sori ano-Raya JJ, Miralbell J, López-Cancio E, BargallóN, Arenillas JF, Barrios M, Cáceres C, Torán P, Alzamora M, Dá valos A, MataróM (2012) Deep versus periventricular white matter lesions and cognitive func tion in a community sample of middle-Aged participants. J Int Neuropsychol Soc 18, 874-885.
18. Patel B, Markus HS (2011) Magnetic resonance imaging in cerebral small vessel disease and its use as a surrogate disease marker. Int J Stroke 6, 47-59.
19. Schmidt R, Petrovic K, Ropele S, enzinger C, Fazekas F (2007) Progression of leukoaraiosis and cognition. Stroke 38, 2619-2625.
20. Norrving B (2008) Lacunar infarcts: No black holes in the brain are benign. Pract Neurol 8, 222-228.
21. Vermeer SE, Longstreth WT Jr., Koudstaal PJ (2007) Silent brain infarcts:Asystematic review. Lancet Neurol 6, 611-619.
22. Norrving B (2003) Long-term prognosis after lacunar infarction. Lancet Neurol 2, 238-245.
23. Benisty S, Gouw AA, Porcher R, Madureira S, Hernández K, Poggesi A, van der Flier WM, Van Straaten EC, Verdelho A, Ferro J, Pa ntoni L, Inzitari D, Barkhof F, Fazekas F, Chabriat H, Study LADIS, group (2009) Location of lacunar infarcts correlates with cognition in a sample of non disabled subjects with age-related white matter changes: The LADIS stud y. J Neurol Neurosurg Psychiatry 80, 478-483.
24. Vermeer SE, Prins ND, den Heijer T, Hofman A, Koudstaal PJ, Breteler MM (2003) Silent brain infarcts and the risk of dementia and cogniti ve decline. N Engl J Med 348, 1215-1222.
25. Debette S, Beiser A, DeCarli C, Au R, Himali JJ,Kelly-Hayes M, Romero JR, Kase CS, Wolf PA, Seshadri S (2010) Association of MRI mark ers of vascular brain injury with incident stroke, mild cognitive impairment, dementia and mortality: The Framingham Offspring Study. Stroke 41, 600-606.
26. Lopez OL, Jagust WJ, Dulberg C, Becker JT, DeKosky ST, Fitzpatrick A, Breitner J, Lyketsos C, Jones B, Kawas C, Carlson M, Kuller LH (2003) Risk factors for mild cognitive impairment in the Cardiovascular Health Study Cognition Study, part 2. Arch Neurol 60, 1394-1399.
27. Van der Flier WM, Cordonnier C (2012) Microbleeds in vascular dementia: Clinical aspects. Exp Gerontol 47, 853-857.
28. Poels MMF, Vernooij MW, Ikram MA, Hofman A, Krestin GP, van der Lugt A, Breteler MM (2010) Prevalence and risk factors of cerebral microbleeds: An update of the Rotterdam scan study. Stroke 41, S103-S106.
29. Yates PA , Villemagne VL, Ellis KA, Desmond PM, Masters CL, Rowe CC (2014) Cerebral microbleeds: A review of clinical, genetic, and neuroimaging associations. Front Neurol 4, 205.
30. Poels MMF, Ikram MA, van der Lugt A, Hofman A, Krestin GP, Breteler MM, VernooijMW(2011) Incidence of cerebral microbleeds in the general population: The Rotterdam Scan Study. Stroke 42, 656-661.
31. Gouw AA, Seewann A, van der Flier WM, Barkhof F, Rozemuller AM, Scheltens P, Geurts JJ (2011) Heterogeneity of small vessel disease: A systematic review of MRI and histopathology correlations. J Neurol Neurosurg Psychiatry 82, 126-135.
32. Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R, Lindley RI, O'Brien JT, Barkhof F, Benavente OR, Black SE, Brayne C, Breteler M, Chab riat H, Decarli C, de Leeuw FE, Doubal F, Duering M, Fox NC, Greenberg S, HachinskiV, Kilimann I,MokV, Oostenbrugge Rv, Pantoni L, Speck O, Stephan BC, Teipel S, Viswanathan A, Werring D, Chen C, Smith C, van Buchem M, Norrving B, Gorelick PB, Dichgans M, STandards for ReportIng Vascular changes on nEuroimaging (STRIVE, v1) (2013) Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol 12, 822-838.
33. Lei C, Lin S, TaoW, Hao Z, Liu M,Wu B (2013) Association between cerebral microbleeds and cognitive function: A systematic review. J Neurol Neurosurg Psychiatry 84, 693-697.
34. Scahill RI, Frost C, Jenkins R, Whitwell JL, Rossor MN, Fox NC (2003) A longitudinal study of brain volume changes in normal aging using serial registere d magnetic resonance imaging. Arch Neurol 60, 989-994.
35. Appelman AP, Exalto LG, van der Graaf Y, Biessels GJ, Mali WP, Geerlings MI (2009) White matter lesions and brain atrophy: More than shared risk factors? A systematic review. Cerebrovasc Dis 28, 227-242.
36. Eckerström C, Olsson E, Klasson N, Bjerke M, Göthlin M, Jonsson M, Rolstad S, Malmgren H, Wallin A, Edman A (2011) High white matter lesion load is associated with hippoc ampal atrophy in mild cognitive impairment. Dement Geriatr Cogn Disord 31, 132-138.
37. Jokinen H, Lipsanen J, Schmidt R, Fazekas F, Gouw AA, van der FlierWM,Barkhof F, Madureira S,Verdelho A , Ferro JM, Wallin A, Pantoni L, Inzitari D, Erkinjuntti T, Study LADIS, Group (2012) Brain atrophy accelerates cognitive decline in cerebral small vessel disease: The LADIS study. Neurology 78, 1785-1792.
38. Polak JF, Pencina MJ, Meisner A, Pencina KM, Brown LS, Wolf PA, D'Agostino RBSR (2010) Associations of carotid artery intima-media thickness (IMT) with risk factors and prevalent cardiovascular disease: Comparison of mean common carotid artery IMT with maximum internal carotid artery IMT. J Ultrasound Med 29, 1759-1768.
39. Auperin A, Berr C, Bonithon-Kopp C, Touboul PJ, Ruelland I, Ducimetiere P, AlperovitchA(1996) Ultrasonographic assessment of carotid wall characteristics and cognitive functions in a community sample of 59-to 71-year-olds. The EVA Study Group. Stroke 27, 1290-1295.
40. Cerhan J R, Folsom AR, Mortimer JA, Shahar E, Knopman DS, McGovern PG, Hays MA, Crum LD, Heiss G (1998) Correlates of cognitive function in middle-Aged adults. Atherosclerosis Risk in Communities (ARIC) Study Investiga tors. Gerontology 44, 95-105.
41. Sander K,Bickel H,Forstl H,Etgen T,Briesenick C,Poppert H,Sander D 2010 Carotid-intima media thickness is independently associated with cognitive decl ine. The INVADE study Int J Geriatr Psychiatry 25, 389-394.
42. Wendell CR, Zonderman AB, Metter EJ, Najjar SS,Waldstein SR (2009) Carotid intimal medial thickness predicts cognitive decline am ong adults without clinical vascular disease. Stroke 40, 3180-3185.
43. Romero JR, Beiser A, Seshadri S, Benjamin EJ, Polak JF, Vasan RS, Au R, DeCarli C, Wolf PA (2009) Caro tid artery atherosclerosis, MRI indices of brain ischemia, aging, and cognitive impairment: The Framingham study. Stroke 40, 1590-1596.
44. Zhong W, Cruickshanks KJ, Huang GH, Klein BE, Klein R, Nieto FJ, Pankow JS, Schubert CR (2011) Carotid atherosclerosis and cognitive function in midlife: The Beaver Dam offspring study. Atherosclerosis 219, 330-333.
45. Xiang J, Zhang T, Yang QW, Liu J, Chen Y, Cui M, Yin ZG, Li L, Wang YJ, Li J, Zhou HD (2013) Carotid artery atherosclerosis is correlated with cognitive impairment in an elderly urban Chinese non-stroke population. J Clin Neurosci 20, 1571-1575.
46. Knopman D, Boland LL, Mosley T, Howard G, Liao D, Szklo M, McGovern P, Folsom AR, Atherosclerosis Risk in Communities (ARIC) Study, Investigators (2001) Cardiovascular ris k factors and cognitive decline in middle-Aged adults. Neurology 56, 42-48.
47. Johnston SC, O'Meara ES, Manolio TA, Lefkowitz D, O'Leary DH, Goldstein S, Carlson MC, Fried LP, Longstreth WT Jr. (2004) Cognitive impairment and decline are associated with carotid artery disease in patients without clinically evident cerebrovascular disease. Ann Intern Med 140, 237-247.
48. Arntzen KA, Schi rmer H, Johnsen SH, Wilsgaard T, Mathiesen EB (2012) Carotid atherosclerosis predicts lower cognitive test results: A 7-year follow-up study of 4,371 stroke-free subjects-the Tromso study. Cerebrovasc Dis 33, 159-165.
49. López-Olóriz J, López-Cancio E, Arenillas JF, Hernández M, Jiménez M, Dorado L, Barrios M, Soriano-Raya JJ, Miralbell J, Cáceres C, Forés R, Pera G, Dávalos A, MataróM (2013) Asymptomatic cervicocerebral atherosclerosis, intracranial vascular resistance and cognition: The AsIANeuropsychology Study. Atherosclerosis 230, 330-335.
50. Reis JP, Launer LJ, Terry JG, Loria CM, Zeki Al Hazzouri A, Sidney S, Yaffe K, Jacobs DR Jr., Withlow CT, Zhu N, Carr JJ (2013) Subclinical atherosclerotic calcification and cognitive functioning in middle-Aged adults: The CARDIA study. Atheroscle rosis 231, 72-77.
51. López-Cancio E, Galán A, Dorado L, Jiménez M, Hernández M, Millán M, Reverté S, Suñol A, Barallat J, Massuet A, Alzamora MT, Dávalos A, Arenill as JF (2012) Biological signatures of asymptomatic extra-And intracranial atherosclerosis: The Barcelona-AsIA (Asymptomatic Intracranial Atherosclerosis) Study. Stroke 43, 2712-2719.
52. Silvestrini M, Paolino I, Vernieri F, Pedone C, Baruffaldi R, Gobbi B, Cagnetti C, Provinciali L, BartoliniM(2009) Cerebral hemodynamics and cognitive performance in patients with symptomatic carotid stenosis. Neurology 72, 1062-1068.
53. Breteler MM, Claus JJ, Grobbee DE, Hofman A (1994) Cardiovascular disease and distribution of cognitive function in elderly people: The Rotterdam study. BMJ 308, 1604-1608.
54. Zhong W, Cruickshanks KJ, Schubert CR, Acher CW, Carlsson CM, Klein BE, Klein R, Chappell RJ (2012) Carotid atherosclerosis and 10-years changes in cognitive function. Atherosclerosis 224, 506-510.
55. de la Torre JC (2012) Cerebral hemodynamics and vascular risk factors: Setting the stage for Alzheimer's disease. J Alzheimers Dis 32, 553-567.
56. Beach TG,Wilson JR, Sue LI, Newell A, Poston M, Cisneros R, Pandya Y, Esh C, Connor DJ, Sabbaqh M, Walker DG, RoherAE(2007) Circle ofWillis atherosclerosis: Association with Alzheimer's disease, neuritic plaques and neurofibrillary tangles. Acta Neuropathol 113, 13-21.
57. Yarchoan M, Xie SX, Kling MA, Toledo JB, Wolk DA, Lee EB, Van Deerlin V, Lee VM, Trojanowski JQ, Arnold SE (2012) Cerebrovascular at herosclerosis correlates with Alzheimer pathology in neurodegenerative dementias. Brain 135, 3749-3756.
58. Keage HA, Churches OF, Kohler M, Pomeroy D, Luppino R, Bartolo ML, Elliott S (2012) Cerebrovascular function in aging and dementia: A systematic review of transcranial Doppler studies. Dement Geriatr Cogn Dis Extra 2, 258-270.
59. Waldstein SR, Rice SC, Thayer JF, Najjar SS, S cuteri A, ZondermanAB(2008) Pulse pressure and pulsewave velocity are related to cognitive decline in the Baltimore Longitudinal Study of Aging. Hypertension 51, 99-104.
60. Singer J, Trollor JN, Baune BT, Sachdev PS, Smith E (2014) Arterial stiffness, the brain and cognition: A systematic review. Ageing Res Rev 15, 16-27.
61. Pase MP, Stoug h C, Grima NA, Harris E, Macpherson E, Scholey AB, Pipingas A (2013) Blood pressure and cognitive function: The role of central aortic and brachial pressures. Psychol Sci 24, 2173-2181.
62. Wersching H,Duning T, Lohmann H,Mohammadi S,Stehling C,Fobker M,Conty M,Minnerup J,Ringelstein EB,Berger K,Deppe M,Knecht S 2010 Serum C-reactive protein is linked to cerebral microstructural integri ty and cognitive function Neurology, 74, 1022-1029.
63. Miralbell J, Soriano JJ, Spulber G, López-Cancio E, Arenillas JF, BargallóN, Galán A, Barrios MT, Cá ceres C, Alzamora MT, Pera G, Kivipelto M, Wahlund LO, Dávalos A, MataróM(2012) Structural brain changes and cognition in relation to markers of vascular dysfunction. Neurobiol Aging 33, 1003. e9-17.
64. Kuo H, Yen C, Chang C, Kuo C, Chen J, Sorond F (2005) Relation of c-reactive protein to stroke, cognitive disorders, and depression in the general population: Systematic review and meta-Analysis. Lancet Neurol 4, 371-380.
65. Miralbell J, López-Oloriz J, López-Cancio E, Soriano JJ, Arenillas JF, Galan A, BarriosMT,Cáceres C, AlzamoraMT, Pera G, Torán P,Dá valos A, MataróM(2013) Cognitive patterns in relation to biomarkers of cerebrovascular disease and vascular risk factors. Cerebrovasc Dis 36, 98-105.
66. Pikula A, Böger RH, Beiser AS, Maas R, DeCarli C, Schwedhelm E, Himali JJ, Schulze F, Au R,Kelly-Hayes M, Kase CS, Vasan RS,Wolf PA, Seshadri S (2009) Association of plasma ADMA levels with MRI markers of vascular brain injury: Framingham Offspring Study. Stroke 40, 2959-2964.
67. Trollor JN, Smith E, Baune BT, Kochan NA, Campbell L, Samaras K, Crawford J, Brodaty H, Sachdev P (2010) Systemic inflammation is associated with MCI and its subtypes: The Sydney memory and aging s tudy. Dement Geriatr Cogn Disord 30, 569-578.
68. Quinn TJ, Gallacher J, Deary IJ, Lowe GDO, Fenton C, Stott DJ (2011) Association between circulating hemostatic measures and dementia or cog nitive impairment: Systematic review and meta-Analyzes. J Thromb Haemost 9, 1475-1482.
69. Stott DJ, Robertson M, Rumley A,Welsh P, Sattar N, Packard CJ, Shepherd J, Trompet S, Westendorp RGJ, de Craen AJ, JukemaJW, BuckleyB, Ford I, LoweGD(2010) Activation of hemostasis and decline in cognitive function in older people. Arterioscler Thromb Vasc Biol 30, 605-611.
70. Debette S, Seshadri S, Beiser A, Au R, Himali JJ, Palumbo C, Wolf PA, DeCarli C (2011) Midlife vascular risk factor exposure accelerates structural brain aging and cognitive decline. Neurology 77, 461-468.
71. Barnes DE, Yaffe K (2011) The projected effect of risk factor reduction on Alzheimer's disease prevalence. Lancet Neurol 10, 819-828.
72. Hamer M, Chida Y (2009) Physical activity and risk of neurodegenerative disease: A systematic review of prospective evidence. Psychol Med 39, 3-11.
73. Hayes SM, Hayes JP, Cadden M, Verfaellie M (2013) A review of cardiorespiratory fitness-related neuroplasticity in the aging brain. Front Aging Neurosci 12, 5-31.
74. Rosenberg GA, BjerkeM,WallinA(2014) Multimodal markers of inflammation in the subcortical ischemic vascular disease type of vascular cognitive impairment. Stroke 45, 1531-1538.